Formulation of nitrogen mustard
AssigneeSuperGen, Inc.
InventorJoseph Rubinfeld
Life of this patent
Estimating the term…
Loading patent…
AssigneeSuperGen, Inc.
InventorJoseph Rubinfeld
Estimating the term…
Compositions of matter comprising a substituted cyclodextrin and cytotoxic compound, especially cytotoxic drugs such as antibiotic, anti-fungal and anti-neoplastic, drugs are claimed. The compositions cause significantly less ulceration compared to the same formulation of cytotoxic compound without cyclodextrin compound when extravasated. The compositions may also cause less vascular irritation compared to the same formulation of cytotoxic compound without cyclodextrin when administered intravenously without extravasation. Compositions of matter comprising watersoluble cytotoxic agents, especially anticancer drugs and anti-ulceration effective or anti-irritatioin effective amounts of cyclodextrin compounds are also claimed. Methods for reducing the likelihood of ulceration and or irritation when administering the compositions according to the invention are also disclosed and claimed.
A composition of matter comprising an anti-ulceration effective amount of a substituted cyclodextrin compound and a nitrogen mustard compound.
A method for reducing ulceration or irritation in a host arising through parenteral treatment of the host with a nitrogen mustard compound that has the potential for causing irritation or ulceration when extravasated, comprising:
Dependencies are inferred from the claim text.